{"result": "(\"entity\"<|>HIPERCOLESTEROLEMIA FAMILIAR HETEROCIGOTA<|>EVENT<|>Hipercolesterolemia familiar heterocigota is a genetic condition characterized by elevated cholesterol levels due to a heterozygous mutation, leading to increased cardiovascular risk.)\n##\n(\"entity\"<|>HIPERTRIGLICERIDEMIA POSPRANDIAL<|>EVENT<|>Hipertrigliceridemia posprandial is a condition characterized by elevated triglyceride levels following meals, often related to dietary habits.)\n##\n(\"relationship\"<|>HIPERCOLESTEROLEMIA FAMILIAR HETEROCIGOTA<|>HIPERLIPIDEMIA FAMILIAR COMBINADA<|>Both conditions are types of familial dyslipidemias that involve abnormal lipid levels in the blood<|>5)\n##\n(\"relationship\"<|>HIPERTRIGLICERIDEMIA POSPRANDIAL<|>HIPERTRIGLICERIDEMIA FAMILIAR<|>Both conditions involve elevated triglyceride levels, but differ in their triggers and genetic basis<|>4)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: -III y A-IV. En muchos individuos se presenta resistencia a la insulina\n         Referencias:                                                                                                                    debido probablemente al flujo de ácidos grasos libres. Los pacientes con hiperlipemia fami-\n         • Cardona F, Alcaide J, Fernández García JC. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española         liar combinada tienen una captación reducida de los ácidos grasos libres procedente de la\n           de Endocrinología y Nutrición; 2015. Capítulo 124. Epidemiología, diagnóstico y clasificación de las dislipemias;\n           [citado 11 de noviembre de 2019]. Disponible en: https://manual.seen.es/article?id=55115050-34cc-451f-99b6-4b97ac18103c.      lipólisis de los triglicéridos en el tejido adiposo. Esto ocasiona un mayor flujo de ácidos gra-\n                                                                                                                                         sos libres hacia el hígado, lo que facilita la sobreproducción hepática de apolipoproteína B\n                                                                                                                                         (apo B) y la síntesis de triglicéridos en forma de lipoproteínas de muy baja densidad (VLDL).\n     26  ¿En cuál de las siguientes dislipidemias es más frecuente encontrar xantomas                                                    Por otra parte, las lipoproteínas ricas en triglicéridos de origen intestinal y hepático perma-\n         tendinosos y arco corneal?                                                                                                      necen más tiempo en plasma. Además, hay un predominio de partículas LDL pequeñas y\n                                                                                                                                         densas, pobres en colesterol y con una tasa elevada de apo B/colesterol, conocidas como\n         A. Hipercolesterolemia poligénica.                                                                                              LDL aterógenas. La frecuencia de la hiperlipidemia familiar combinada es de un 0,5-1% en\n         B. Hipertrigliceridemia familiar.                                                                                               la población norteamericana y estos sujetos no presentan xantomas.\n         C. Hipercolesterolemia familiar heterocigota.                                                                                   Referencias:\n         D.  Hiperlipidemia familiar combinada.                                                                                          • Cardona F, Alcaide J, Fernández García JC. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española\n                                                                                                                                           de Endocrinología y Nutrición; 2015. Capítulo 124. Epidemiología, diagnóstico y clasificación de las dislipemias;\n                                                                                                                                           [citado 11 de noviembre de 2019]. Disponible en: https://manual.seen.es/article?id=55115050-34cc-451f-99b6-4b97ac18103c.\n                                                                                                                                         • Mata P, Alonso R, Ruíz-Garcia A, Díaz-Díaz JL, González N, Gijón-Conde T, et al. Hiperlipidemia familiar combinada: documento de\n         COMENTARIO                                                                                                                        consenso. Medicina de Familia. SEMERGEN. 2014;40(7):374-380.\n         Hipercolesterolemia poligénica. La mayoría de las hipercolesterolemias moderadas (ni-\n         veles de colesterol plasmático 240-350 mg/dl) son de origen poligénico. Esto quiere decir                                   27  El genotipo de la apolipoproteína E con las isoformas E2/E2 se asocia a la\n         que intervienen numerosos genes que interactúan con el medio ambiente y provocan la                                             siguiente dislipidemia:\n         hipercolesterolemia y pueden ser responsables tanto de la producción excesiva como de\n         la disminución del catabolismo de las LDL. Se presentan niveles normales de triglicéridos y                                     A. Hipercolesterolemia homocigota.\n         colesterol HDL. No existen xantomas.                                                                                            B. Disbetalipoproteinemia familiar.\n         Hipertrigliceridemia familiar.           Parece ser transmitida como un trastorno autosómico do-                                C. Hiperlipidemia familiar combinada.\n         minante, pero no se ha identificado la mutación o mutaciones responsables. Se caracte-                                          D.  Hipertrigliceridemia posprandial.\n         riza tanto por una disminución del catabolismo de las VLDL como por un aumento de su\n\n\n\n452                                                                                                                                                                                                                                                                 453\n---\n                                                                                                                                                                                                                       OBESIDAD,               LÍPIDOS                    8\n                                                                                                                                                                                          Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n     COMENTARIO                                                                                                                                  28  ¿Qué asociación de fármacos hipolipemiantes se ha relacionado con un discreto\n     Disbetalipoproteinemia. Este trastorno es raro, con una frecuencia de una por cada                                                              aumento de las miopatías?\n     10.000 personas, y fundamentalmente se debe a una homocigosis en la apo E, presentan-                                                           A. Estatinas + Fibratos.\n     do el genotipo apo E2 en homocigosis. Dado que la apo E desempeña un papel crucial en\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Sociedad Española de Endocrinología y Nutrición is an organization based in Madrid that focuses on endocrinology and nutrition, providing guidelines and resources for medical professionals.)\n##\n(\"entity\"<|>CARDONA F<|>PERSON<|>Cardona F is an author of the Manual de Endocrinología y Nutrición, contributing to the field of endocrinology and nutrition.)\n##\n(\"entity\"<|>ALCAIDE J<|>PERSON<|>Alcaide J is a co-author of the Manual de Endocrinología y Nutrición, involved in research and education in endocrinology and nutrition.)\n##\n(\"entity\"<|>FERNÁNDEZ GARCÍA JC<|>PERSON<|>Fernández García JC is a co-author of the Manual de Endocrinología y Nutrición, contributing to the understanding of endocrinology and nutrition.)\n##\n(\"entity\"<|>HIPERLIPIDEMIA FAMILIAR COMBINADA<|>EVENT<|>Hiperlipidemia familiar combinada is a medical condition characterized by elevated levels of lipids in the blood, often requiring clinical attention and management.)\n##\n(\"entity\"<|>HIPERCOLESTEROLEMIA POLIGÉNICA<|>EVENT<|>Hipercolesterolemia poligénica is a common condition involving elevated cholesterol levels due to genetic and environmental factors.)\n##\n(\"entity\"<|>HIPERTRIGLICERIDEMIA FAMILIAR<|>EVENT<|>Hipertrigliceridemia familiar is a genetic disorder characterized by high triglyceride levels in the blood, which can lead to various health issues.)\n##\n(\"entity\"<|>DISBETALIPOPROTEINEMIA<|>EVENT<|>Disbetalipoproteinemia is a rare genetic disorder associated with abnormal lipid metabolism, particularly involving apolipoprotein E.)\n##\n(\"relationship\"<|>CARDONA F<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Cardona F is an author associated with the Sociedad Española de Endocrinología y Nutrición, contributing to its publications<|>7)\n##\n(\"relationship\"<|>ALCAIDE J<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Alcaide J is a co-author associated with the Sociedad Española de Endocrinología y Nutrición, contributing to its publications<|>7)\n##\n(\"relationship\"<|>FERNÁNDEZ GARCÍA JC<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Fernández García JC is a co-author associated with the Sociedad Española de Endocrinología y Nutrición, contributing to its publications<|>7)\n##\n(\"relationship\"<|>HIPERLIPIDEMIA FAMILIAR COMBINADA<|>HIPERCOLESTEROLEMIA POLIGÉNICA<|>Both conditions are types of dyslipidemia that involve abnormal lipid levels in the blood<|>5)\n##\n(\"relationship\"<|>HIPERLIPIDEMIA FAMILIAR COMBINADA<|>HIPERTRIGLICERIDEMIA FAMILIAR<|>Both conditions are types of dyslipidemia that involve abnormal lipid levels in the blood<|>5)\n##\n(\"relationship\"<|>HIPERTRIGLICERIDEMIA FAMILIAR<|>DISBETALIPOPROTEINEMIA<|>Both conditions are related to lipid metabolism disorders<|>4)\n<|COMPLETE|>"}]}